Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-16-052230
Filing Date
2016-02-12
Accepted
2016-02-12 16:06:25
Documents
1
Group Members
SAK CORPSETH A. KLARMAN

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 115583
  Complete submission text file 0001140361-16-052230.txt   117136
Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Filed by) CIK: 0001061768 (see all company filings)

EIN.: 043402144 | State of Incorp.: MA
Type: SC 13G/A

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 161418935
SIC: 2834 Pharmaceutical Preparations